The trial was tiny, just 16 patients, but it’s eliciting a sentiment not normally associated with this brutal disease of ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...

These vaccines work by stimulating the body's immune response against cancer cells, often by training immune cells (like T ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

In the seriously great news department, pancreatic cancer is expected to pass colorectal cancer as the second biggest cause ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

A new study published in the journal Nature emphasizes the promise of a personalized vaccine, autogene cevumeran, in treating ...

Friends, family, and the Cathedral Prep community gathered at the Hagerty Family Events Center to honor the legendary Pat ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...

Thanks to decades of sustained, predictable federal investments and increases in pancreatic cancer research, the research ...